ORIGINAL RESEARCH article
Front. Neurosci.
Sec. Neurodegeneration
Volume 19 - 2025 | doi: 10.3389/fnins.2025.1662530
This article is part of the Research TopicIron Dysregulation, Oxidative Stress, and Inflammation: Mechanisms and Therapeutic InsightsView all articles
Evaluating the Efficacy of Probiotics in Treating Parkinson's Disease Model Rats Using Magnetic Resonance Enhanced Gradient Echo T2-weighted Angiography Sequence
Provisionally accepted
- 1First Hospital of Qinhuangdao, Qinhuangdao, China
- 2Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Parkinson's disease (PD) involves iron deposition in the substantia nigra (SN) and loss of dopaminergic neurons, with gut microbiota dysbiosis potentially affecting the brain iron via the gut–brain axis, whereas magnetic resonance enhanced gradient echo T2-weighted angiography (ESWAN) enables non-invasive iron assessment. Currently, for the detection of brain iron content, traditional tissue biopsy can provide accurate pathological information. However, its clinical and scientific research applications are limited owing to its invasiveness, difficulty in repeated operations, and other limitations. This study aimed to evaluate the therapeutic efficacy of probiotics and underlying mechanisms in PD rats using ESWAN. Twenty-seven male Sprague–Dawley rats were divided into control, PD model, and probiotic treatment groups. PD models were established by 6-hydroxydopamine stereotaxic injection into the SN, whereas the treatment group received oral gavage of Lactobacillus acidophilus and Bifidobacterium bifidum mixture. ESWAN was used to quantify iron deposition, complemented by iron histochemical staining and wire grip tests for motor function assessment. The probiotic treatment significantly reduced right SN R2* values (p<0.0001) and iron staining optical density (p<0.0001), and prolonged the time of wire grip duration (p<0.0001) compared with PD rats, though not fully to control levels. Mechanistically, probiotics likely alleviated iron overload via gut–brain axis modulation, antioxidant enzyme enhancement, and blood–brain barrier maintenance. The strong positive correlation (r≥0.7) between ESWAN-derived R2* values and iron staining confirmed ESWAN as a reliable non-invasive tool for brain iron assessment. This study provides experimental evidence that probiotics mitigate SN iron deposition in PD rats by regulating gut microbiota, highlighting ESWAN as a potential imaging biomarker for early PD diagnosis and therapeutic monitoring.
Keywords: Parkinson's disease, Probiotics, ESWAN Sequence, Substantia Nigra, iron deposition, Gut–brain axis
Received: 09 Jul 2025; Accepted: 02 Sep 2025.
Copyright: © 2025 Su, Dong, Feng, Zhang, Yu and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hongzhi Lu, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.